Abstract
Data on the clinical profile, echocardiographic findings, and outcome of acute fulminant myocarditis (AFM) in children from resource limited countries are limited. To study the clinical profile and short-term outcomes of children aged 2 months to 17 years with AFM managed with only supportive care. We enrolled all children admitted with AFM in our hospital from January 2009 to October 2010. Although the information on patients admitted from January 2009 to March 2010 were retrieved from the case records, data of children admitted from April 2010 were recorded prospectively. AFM was diagnosed based on clinical and echocardiographic criteria. We collected information regarding clinical course, treatment details, and echocardiography findings using a structured performa. All of the children, including those for whom baseline information was collected from the records, were followed-up prospectively to determine short-term outcomes. A total of 10 children, of whom 6 were male, presented with AFM. Their median age was 7.5 (interquartile range [IQR] 2 to13) years, and the mean left-ventricular ejection fraction (LVEF) was 26% (SD 11.5). Of the 10 children, 9 were discharged, and 1 child died. At discharge, all children showed improvement in the symptoms, but only 4 had improvement in LV function on echocardiography. Factors associated with poor recovery of LV function at discharge were anasarca, low LVEF, and increased serum glutamate pyruvate transaminase levels at admission. One child had died at 2-month follow-up, and another child developed dilated cardiomyopathy at 15 months after discharge. Children with AFM had good immediate- and short-term outcomes even without the use of mechanical assist devices. Decreased LVEF at admission was found to be one of the most important determinants of poor immediate outcomes in these children.
Similar content being viewed by others
References
Ahdoot J, Galindo A, Alejos JC, George B, Burch C, Marelli D et al (2000) Use of OKT3 for acute myocarditis in infants and children. J Heart Lung Transpl 19:1118–1121
Al-Biltagi M, Issa M, Hagar HA, Abdel-Hafez M, Aziz NA (2010) Circulating cardiac troponin levels and cardiac dysfunction in children with acute and fulminant viral myocarditis. Acta Paediatr 99:1510–1516
Amabile N, Fraisse A, Bouvenot J, Chetaille P, Ovaert C (2006) Outcome of acute fulminant myocarditis in children. Heart 92:1269–1273
Bowles NE, Ni J, Kearney DL, Pauschinger M, Schultheiss HP, McCarthy R et al (2003) Detection of viruses in myocardial tissues by polymerase chain reaction. Evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 42:466–472
Calabrese F, Rigo E, Milanesi O, Boffa GM, Angelini A, Valente M et al (2002) Molecular diagnosis of myocarditis and dilated cardiomyopathy in children: clinicopathologic features and prognostic implications. Diagn Mol Pathol 11:212–221
Cooper LT (2007) Giant cell myocarditis in children. Prog Pediatr Cardiol 24:47–49
Dennert R, Velthuis S, Schalla S, Eurlings L, van Suylen RJ, van Paassen P et al (2010) Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral load. Antivir Ther 15:193–201
Drucker NA, Colan SD, Lewis AB, Beiser AS, Wessel DL, Takahashi M et al (1994) Gamma-globulin treatment of acute myocarditis in the pediatric population. Circulation 89:252–257
Duncan BW, Bohn DJ, Atz AM, French JW, Laussen PC, Wessel DL (2001) Mechanical circulatory support for the treatment of children with acute fulminant myocarditis. J Thorac Cardiovasc Surg 122:440–448
English RF, Janosky JE, Ettedgui JA, Webber SA (2004) Outcomes for children with acute myocarditis. Cardiol Young 14:488–493
Freixa X, Sionis A, Castel A, Guasch E, Loma-Osorio P, Arzamendi D et al (2009) Low troponin-I levels on admission are associated with worse prognosis in patients with fulminant myocarditis. Transplant Proc 41:2234–2236
Haque A, Bhatti S, Siddiqui FJ (2009) Intravenous immune globulin for severe acute myocarditis in children. Indian Pediatr 46:810–811
Kim HJ, Yoo GH, Kil HR (2010) Clinical outcome of acute myocarditis in children according to treatment modalities. Korean J Pediatr 53:745–752
Levi D, Alejos J (2001) Diagnosis and treatment of pediatric viral myocarditis. Curr Opin Cardiol 16:77–83
Lieberman EB, Hutchins GM, Herskowitz A, Rose NR, Baughman KL (1991) Clinicopathologic description of myocarditis. J Am Coll Cardiol 18:1617–1626
McCarthy RE 3rd, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM et al (2000) Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 342:690–695
McNamara DM, Holubkov R, Starling RC, Dec GW, Loh E, Torre-Amione G et al (2001) Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation 103:2254–2259
Pophal SG, Sigfusson G, Booth KL, Bacanu SA, Webber SA, Ettedgui JA et al (1999) Complications of endomyocardial biopsy in children. J Am Coll Cardiol 34:2105–2110
Reiss N, El-Banayosy A, Arusoglu L, Blanz U, Bairaktaris A, Koerfer R (2006) Acute fulminant myocarditis in children and adolescents: The role of mechanical circulatory assist. ASAIO J 52:211–214
Robinson J, Hartling L, Vandermeer B, Crumley E, Klassen TP (2005) Intravenous immunoglobulin for presumed viral myocarditis in children and adults. Cochrane Database Syst Rev (1):CD004370
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sankar, J., Khalil, S., Jeeva Sankar, M. et al. Short-Term Outcomes of Acute Fulminant Myocarditis in Children. Pediatr Cardiol 32, 885–890 (2011). https://doi.org/10.1007/s00246-011-0007-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-011-0007-8